Ratiopharm to go under the hammer as Merckle gets loan The conglomerate run by German billionaire Adolf Merckle, who committed suicide two days ago, has secured a vital bridging loan from banks but has had to put generic drugmaker Ratiopharm up for sale in doing so
PDUFA date for Ipsen's Reloxin put back to April 13 Ahead of holding its first investor day, French drugmaker Ipsen has suffered a setback with the news that US health regulators is delaying a decision over approving Reloxin, a potential competitor to Allergan’s Botox
